6 news items
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
financial advice or an endorsement of ATNM or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
JAZZ
30 May 24
only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the XYWAV and XYREM REMS
NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
JAZZ
28 May 24
strategy and we are delighted that NodThera will continue to benefit from his expertise in his new role." Daniel Swisher
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
JAZZ
2 May 24
-to-equity ratio of 1.55, Jazz Pharmaceuticals adopts a prudent financial strategy, indicating a balanced approach to debt management
lg9edqpo
JAZZ
10 Apr 24
only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the XYWAV and XYREM REMS
- Prev
- 1
- Next